BGM

NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Dollar change +1.02
Percentage change 8.81	%

Peers: CAH MCK A TMO ILMN LH DGX CRL BIO CCEC

| Held by: PGJ

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.25	Insider Own	13.72%	Shs Outstand	145.79M	Perf Week	14.21%
Market Cap	1.83B	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	125.80M	Perf Month	29.95%
Income	-1.44M	PEG	-	EPS next Q	-	Inst Own	0.06%	Short Float	0.02%	Perf Quarter	18.51%
Sales	25.10M	P/S	72.84	EPS this Y	-	Inst Trans	0.07%	Short Ratio	0.89	Perf Half Y	69.00%
Book/sh	5.91	P/B	2.12	EPS next Y	-	ROA	-2.77%	Short Interest	0.02M	Perf Year	264.01%
Cash/sh	0.12	P/C	100.79	EPS next 5Y	-	ROE	-3.37%	52W Range	2.70 - 14.78	Perf YTD	48.40%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-3.38%	52W High	-15.16%	Beta	1.32
Dividend TTM	-	Quick Ratio	2.73	Sales past 5Y	-7.62%	Gross Margin	11.47%	52W Low	364.44%	ATR (14)	0.75
Dividend Ex-Date	-	Current Ratio	3.39	EPS Y/Y TTM	-12.78%	Oper. Margin	-2.25%	RSI (14)	63.21	Volatility	5.88% 6.75%
Employees	323	Debt/Eq	0.00	Sales Y/Y TTM	-45.99%	Profit Margin	-5.75%	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	0.00	EPS Q/Q	-11.02%	Payout	-	Rel Volume	0.38	Prev Close	11.52
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-27.57%	Earnings	-	Avg Volume	21.32K	Price	12.54
SMA20	11.12%	SMA50	16.15%	SMA200	43.93%	Trades		Volume	8,088	Change	8.81%

May-02-25 08:30AM	BGM Group Announces Strategic Acquisition of HM Management to Expand AI Application Ecosystem (PR Newswire)
Apr-28-25 08:30AM	BGM Completes Acquisition of YX to Advance AI-Powered Intelligent Platform (PR Newswire)
Apr-21-25 08:30AM	BGM Group Acquires Wonder Dragon to Accelerate 'Healthcare' Strategy (PR Newswire)
Mar-19-25 08:30AM	BGM Acquires YX to Strengthen AI Strategy for Its Intelligent Platform (PR Newswire)
Feb-28-25 08:30AM	BGM Group Announces Board Reshuffle: New Leadership Embarks on a Transformative Journey Amid Tech Revolution (PR Newswire)
07:30AM	Loading…
Feb-19-25 07:30AM	BGM Group Establishes 'Duxiaobao Management Committee' to Accelerate AI Strategy and Drive Intelligent Transformation in the Insurance Industry (PR Newswire)
Dec-27-24 09:30AM	BMG Completed Acquisition of High-Quality Assets, Marking a New Chapter in Diversified Growth (PR Newswire)
09:05AM	In-Depth Analysis of BGM Group: Innovating Pharmaceuticals and Insurance through AI (PR Newswire)
09:00AM	AIX Completes Strategic Share Exchange with BGM to Drive Growth in AI Insurance and Healthcare (GlobeNewswire)
Dec-19-24 08:30AM	BGM Group and Jointown Deepen Cooperation, Ushering in a New Era of Pharmaceutical Development (PR Newswire)
Nov-29-24 10:58AM	BGM Group Ltd Pioneers Innovation in AI Technology, Fostering Holistic Integration of Healthcare and Insurtech (PR Newswire) +22.50%
10:58AM	/C O R R E C T I O N -- BGM Group Ltd/ (PR Newswire)
10:11AM	AIX Inc. (NASDAQ:AIFU): Reshaping AI Insurance and the Healthcare Industry--A Promising Future Ahead? (PR Newswire)
09:00AM	AIX and BGM Group Forge Strategic Deal, Leading Healthcare, Pharma, and Insurance Industry Expansion with AI (GlobeNewswire)
Nov-28-24 06:32AM	Qilian International Announces Major Share Subscription Deal (TipRanks)
08:30AM	Loading…
Nov-22-24 08:30AM	BGM Group Welcomes Guilin Pharma for On-site Audit and Partnership Development (PR Newswire)
Oct-29-24 08:00AM	Qilian International Holding Group Limited Announces Name Change to BGM Group Ltd. (PR Newswire)
Aug-13-24 08:00AM	Qilian International Holding Group Ltd. Announces Trading Ticker Symbol to "BGM" (PR Newswire)

BGM Group Ltd. is a pharmaceutical and chemical company. It focuses on the research, development, manufacture, marketing, and sale of oxytetracycline products, licorice products, traditional Chinese medicine derivatives product, heparin product, sausage casings, and fertilizers. The Licorice products include Gan Di Xin, Qilian Shan Licorice Extract, and Qilian Shan Licorice Liquid Extract. The Oxytetracycline products consists of Qilian Shan Oxytetracycline Tablets and Qilian Shan Oxytetracycline Active Pharmaceutical Ingredients (API). The TCMD product includes Ahan antibacterial paste, which is made from a mixture of traditional Chinese herbal ingredients. The heparin product includes Heparin Sodium Preparations. The Sausage Casings products include Zhu Xiaochang Sausage Casings, which are all-natural food products used for culinary purposes. The Fertilizer products is composed of Xiongguan Organic Fertilizer and Xiongguan Organic-Inorganic Compound Fertilizer. The company was founded on February 7, 2019 and is headquartered in Chengdu, China.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BGM Group Ltd

Upgrade your FINVIZ experience